Clinical trial · Observational
Shared Care Follow-up After Chemotherapy for Testicular Cancer
NCT01783145CI-TRIAL-00090165SCFU-TCactive not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to develop and evaluate a shared care survivorship care plan (SCP) to follow-up patients with metastatic testicular cancer after completion of chemotherapy that resulted in complete remission.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Testicular Cancer | Malignant Testicular Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Patients
- description
- Patients with disseminated TC who have finished their chemotherapy, if needed followed by surgery, and who are in complete remission and currently in active follow-up.
Primary outcomes (2)
- measure
- Safety of a shared care survivorship care plan (SCP).
- timeFrame
- Monitoring of safety will be done on a continuous basis with average duration of two years per participant.
- description
- The aim of this study is to develop and evaluate a shared care SCP to follow-up patients with disseminated TC after completion of chemotherapy. Participants in the SCP will be patients, GPs and oncologists. The SCP will be defined according to follow-up guidelines for TC patients, with a focus on disease relapse and late effects.
- measure
- Feasibility of a shared care survivorship care plan (SCP).
- timeFrame
- Monitoring of feasibility will be done on a continuous basis with average duration of two years per participant.
- description
- The aim of this study is to develop and evaluate a shared care SCP to follow-up patients with disseminated TC after completion of chemotherapy. Participants in the SCP will be patients, GPs and oncologists. The SCP will be defined according to follow-up guidelines for TC patients, with a focus on disease relapse and late effects.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with disseminated testicular cancer; * Complete remission after chemotherapy with or without adjunctive surgery and in active follow-up; * Age 18 years or older; * Started with chemotherapy after January 1st 2003; * Written informed consent. Exclusion Criteria: •Mental disability
References
Publications (0)
Data not yet available
No reference posted for this study.